Indeed, several animal studies have suggested that the administration of inhibitors for DNA sensors including TLR9 and STING attenuates the development of several lifestyle-related diseases such as insulin resistance, hepatic diseases, and atherosclerosis. Here, TLR9 is linked to atherosclerosis.